Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “urinary bladder”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 55 records · Page 3Linked to original sources
PubMedDate not supplied

[Set of trocars for drainage of the urinary bladder in acute urinary retension].

At present urologists give preference to drawing the urine by puncturing the anterior wall of. the urinary bladder by means of a trochar with introduction of a drain-tube. A set of 3 types of trochar-drain tubes of a similar construction but differing in their diameter are proposed for superpubical drawing of the urine. By using a simple in its arrangement and a little-traumatic trochar-drain tube a single-stage cystotomy can also be effected with the help of Foley, Maleko or Pezzer's catheters. Not a single of 152 patients subjected to superpubical drainage with these instruments suffered any complications.

Acute Disease↗
PubMed2006

A comparison of engineered urinary bladder and intestinal smooth muscle for urinary bladder wall replacement in a rabbit model.

BACKGROUND/PURPOSE: The small intestine is the most common resource for bladder augmentation. Little is known whether intestinal smooth muscle cells (SMCs) may be engineered into bladder tissue. We investigated the phenotypic and functional characteristics of engineered bladder and intestinal SMCs as bladder wall replacement in a rabbit model. METHODS: One month after an initial 70% partial cystectomy, 3 autoaugmentation surgeries were performed, including traditional autoaugmentation (TA, n = 6), TA using engineered bladder SMCs (TA + B, n = 6), and TA using intestinal SMCs (TA + I, n = 6). All were followed up by bladder volume measurement and retrieved on the first, third, and sixth month. The grafts and the native bladder wall were evaluated with immunocytochemistry and electrical field stimulation (EFS). Statistical analysis was performed using analysis of variance. RESULTS: Both the TA + I and TA + B groups showed significant and similar bladder capacity increment in all time points. The engineered muscle cells demonstrated the typical "contraction-relaxation" response to supramaximal EFS. There were no statistical differences in both the TA + I and TA + B groups in contractility force. CONCLUSION: Engineered SMCs derived from urinary bladder and small intestine could retain their phenotype after implantation in vivo. Both exhibited a similar degree of contractility to EFS. These results suggest that there are no phenotypic or functional differences between muscle cells obtained from the 2 different organs. Both have the potential to be engineered into normal bladder tissues.

Animals↗
PubMedDate not supplied

[One-stage transurethral resection of the urinary bladder and the prostate in patients with superficial cancer of the urinary bladder combined with benign prostatic hyperplasia].

Combination of urinary bladder cancer (UBC) with benign prostatic hyperplasia (BPH) is a prognostically unfavourable factor. To assess clinical efficacy of one-stage transurethral resection of UBC and BPH in combination with adjuvant immunotherapy, we examined 181 patients with UBC stage Tis, Ta-T1 and BTH. All the patients have undergone one- and two-stage endoscopic operations. TUR of the urinary bladder and the prostate was made in 87 patients. Stage-by-stage TUR of the urinary bladder and TUR of the prostate were made in 94 controls. We conducted postoperative immunotherapy with BCG vaccine (imuron) as an adjuvant therapy in 114 (63%) patients. Postoperative UBC recurrence occurred in 124 (68.5%) patients: 49 (56.3%) patients of the study group and 75 (79.7%) controls (p < 0.05). Reoperation (TUR of the urinary bladder) was performed in all cases of UBC recurrence. Five-year survival in the study group was 71% and 68.0% survived in the control group (p > 0.05). The conclusion is made that in combination of superficial UBC with BPH indications appear for TUR of the urinary bladder and TUR of the prostate with adjuvant immunotherapy. Early elimination of infravesical obstruction lowers UBC recurrence rate and improves the patients' quality of life.

Adjuvants, Immunologic↗
PubMed1983

[Histological study of urinary bladder tumor: DNA of rat urinary bladder tumor caused by N-butyl-N-(4-hydroxybutyl) nitrosamine and that of human bladder tumor].

Male Fisher rats were treated with 0.5% BBN, and the appearance of cancer in the rat's bladder was observed successively. The quantities of DNA in the normal and tumorous tissues were compared with those in the bladder cancer excised from man; and, the bladder cancer produced in the rat and that occurring in man were compared. 96 rats were divided into 4 groups, and given 8, 16, 24 or 32 weeks of treatment with BBN. Papillomas appeared after administration for 8 weeks, and with subsequent increase in the period of administration the rate of canceration increased. The cancerous tissue proliferated papillarily , the malignancy was grade 1 to 2, no case showed infiltration into the muscle layer, and the quantity of DNA scarcely changed with time, always showing a peak near 2c. In the papillary type of bladder cancer in man, the quantity of DNA showed little change at any stage, and little tendency of infiltration; and, the growth pattern was similar to that of the BBN-induced cancer in rats. On the other hand, non-papillary cancer in man showed a flat histogram of DNA, had a strong tendency of infiltration, and showed a growth pattern different from that of the BBN-induced cancer in rats, thus the BBN-induced cancer in the rat cannot be used as a model of non-papillary infiltrative cancer.

Animals↗
PubMed2003

NMP22 in transitional cell carcinoma of the urinary bladder.

BACKGROUND: Urinary bladder transitional cell carcinoma (TCC) is a common cancer encountered in the human urinary system. The detection of new and recurrent TCC of the urinary bladder was performed using nuclear matrix (NMP22) kit and compare to the urine cytology. METHODS: Ninety-two patients were included and divided to 3 groups. The first group was composed of patients for detection of recurrence of TCC of the urinary bladder in follow-up check. The second group consisted of patients who had microscopic or gross hematuria. The third group was volunteers. A urine sample was obtained from every enrolled patient. Followed by cystourethroscopy, the urine cytoloy, urine analysis and NMP 22 were performed respectively. A receiver operating characteristics (ROC) curve was constructed to determine NMP22 cutoff value for optimal sensitivity and specificity to detect bladder tumor. The data was then analyzed with Student-t test. RESULTS: ROC curve showed an optimal value of greater than 10 units per mL in differentiating positive from negative results. The sensitivity of NMP22 was 91.7% (22/24) and the specificity was 72.1% (49/68) in detection of TCC. The sensitivity and specificity of cytology were 37.5% (9/24) and 97.1% (66/68), respectively. The positive predictive values of NMP22 and cytology were 53.7% and 81.8%, individually. The false-positive rate of NMP22 was 27.9%. More sensitivity was observed in the NMP22 test with regards to high-grade and advanced-stage tumors. CONCLUSIONS: NMP22 is a highly sensitive tumor marker. However, high false positive rate and unsatisfactory positive predictive value are the drawbacks of this new tumor marker assay. There is inadequate evidence to consider total replacement of cytology with NMP22. But combination of NMP22 and cytology could be the most complete way to avoid unnecessary cystoscopic surveillance.

Aged↗
PubMed1993

Stimulation of phosphoinositides by agents that stimulate proton secretion in toad urinary bladder.

The urinary bladder of Bufo marinus excretes H+ and this excretion is increased by metabolic acidosis (MA), insulin (IN), prostaglandin E2 (PGE2), increases CO2, and aldosterone. The purpose of this experiment was to determine whether MA, IN, PGE2, CO2, and aldosterone stimulate inositol phosphate's (IP) formation in isolated cells of toad urinary bladder. Cells were prepared by treating bladder sacs with collagenase. Cells were obtained from 10 toads in MA and 10 normal toads, suspended in 2 ml of Ringer's solution containing LiCl (10 mM), myo-inositol (5 mM), and [3H]myo-inositol (10 microCi), and then incubated for 2 hr at 25 degrees C. Cells were homogenized and the IP fractions quantitated by column chromatography and liquid scintillation counting. The results were expressed as dpm (mu MPO4)-1 (hr)-1. The IP in MA cells was 44,202 +/- 4,646 and in normal toad cells it was 31,637 +/- 3,613 (P < 0.05). In a separate experiment, cells from 10 paired hemibladders were isolated from normal toads. The cells were treated exactly as above except there were no LiCl in the bath. LiCl was added to all baths after 2 hr and the experimental cells were challenged with IN, PGE2, increases CO2, and aldosterone for 20 min. The IP were quantitated as above. IN treatment stimulated inositol bisphosphate and inositol triphosphate (P < 0.01). PGE2 and increases CO2 also stimulated inositol triphosphate (P < 0.05). Aldosterone did not alter formation of any of the IP fractions. We conclude that MA, IN, PGE2, and increases CO2 stimulate IP formation in cells of toad urinary bladder and inositol triphosphate may be an important second messenger in mediating the response of MA, IN, PGE2, and increases CO2.

Acidosis↗
PubMed1983

The role of the adrenal gland in control of H+ and NH4+ excretion by toad urinary bladder.

The urinary bladder of Bufo marinus has been shown to excrete H+ and NH4+ and this excretion is increased by metabolic acidosis. The involvement of the adrenal gland and its steroid secretions in the adaptation for increased acid and ammonia excretion by the bladder was tested during the course of this study. Groups of toads were adrenalectomized and maintained in chronic NH4Cl-induced acidosis. Three other groups of toads were adrenalectomized and put in acidosis but repleted with 2.5 mg/day of either cortisol (CT), dexamethasone (Dexa), or deoxycorticosterone acetate (DOCA). All control groups were sham-operated. The bladders were excised after 3 days and mounted between 2-ml Lucite chambers. Net H+ and NH4+ fluxes into the mucosal media were measured and reported in units of nanomoles per 100 mg bladder per minute. In control acidotic toads H+ excretion was 20.1 +/- 2.0 and the adrenalectomized nonreplete group H+ excretion was 14.2 +/- 1.87 (P less than 0.04). For the same groups NH4+ excretion was 2.90 +/- 0.26 for the controls and 1.38 +/- 0.19 for the adrenalectomized (P less than 0.001). The H+ excretion in CT-, Dexa-, and DOCA-repleted toads was not significantly different from the control group. NH4+ excretion, however, showed a 55% decrease (P less than 0.001) in the CT group, and a 45% decrease (P less than 0.05) in the Dexa group. The NH4+ excretion in the DOCA repleted group was significantly different from the control group. Therefore, we conclude that the adrenal gland plays a role in the adaptive increase of H+ and NH4+ excretion by the urinary bladder in acidosis through the secretion of steroid hormones. The increase in NH4+ excretion appears to be a mineralocorticoid-stimulated process. We were not able to determine in this study if the steroid hormones had an exacting regulatory role or one of a permissive role over H+ and NH4+ excretion in the toad urinary bladder.

Acid-Base Equilibrium↗
PubMed1999

Metabolic aspects of urinary bladder filling.

Urinary bladder compliance allows the bladder to fill to near capacity without a large increase in intravesical pressure. Bladder compliance is composed of two interrelated factors: passive characteristics of the connective tissue elements of the bladder, and active properties of the smooth muscle elements. The tension generated by the smooth muscle elements can significantly affect bladder compliance. This study utilized an in-vitro whole-bladder model in rabbits to determine the effects of hypoxia, alterations in calcium concentrations, and muscarinic agonists and antagonists on bladder capacity and compliance. The urinary bladder was excised together with a short segment of proximal urethra. A catheter was inserted into the bladder via the dome and the urethra was canulated with a saline-filled tube. The bladder was mounted in an isolated bath containing Tyrode's buffer. The catheter was connected to a pressure transducer to monitor the intravesical pressure and connected to a saline-filled i.v. bag. The weight of the saline bag was continually monitored. The height of the saline bag was set to 80 mmH2O above the baseline intravesical pressure. Bladder filling was started by opening the bladder to the saline reservoir. Intravesical pressure, rate of pressure increase, rate of volume increase, and maximal volume were digitally recorded. The bladder filling was repeated while the whole bladder was subjected to hypoxia, high calcium concentration, the presence of EGTA, carbachol, atropine and tetrodotoxin, respectively. Results are summarized as follows: (a) control bladder filling was biphasic, there was an initial rapid rise in intravesical pressure followed by a slower linear rise to the pre-set pressure; (b) hypoxia significantly decreased the initial rate of the rise in intravesical pressure, increased the rate of bladder filling, and significantly increased final bladder volume; (c) incubation of the bladder in the presence of EGTA also significantly decreased the initial rate of intravesical pressure rise, increased the rate of filling and also significantly increased the final bladder volume; (d) high concentrations of calcium increased the initial rate of rise in intravesical pressure; (e) carbachol significantly increased the rate of intravesical pressure rise, decreased the rate of bladder filling, and significantly decreased final bladder volume; (f) atropine and tetrodotoxin (TTX) had no effects on bladder filling. In summary, alterations in muscle tone had significant effects on bladder capacity and compliance.

Animals↗
PubMed2004

FISH--a new noninvasive method for the diagnosis of urinary bladder carcinomas.

Urinary bladder carcinoma is one of the most frequent malignant tumour diseases. The frequency increases with advancing age. The knowledge increase about genetic changes in tumour cells opens the possibility of a new noninvasive diagnosis with the help of fluorescence in situ hybridization (FISH). Comparable data are obtained by application of different diagnostic methods (fluorescence in situ hybridization, urinary bladder cancer ELISA, urinary cytology, histopathology) at different times from 6 coincidentally selected patients (preoperation, biopsy material and postoperation). The FISH test proved to be a sensitive method and correlated with the histopathological data.

Biopsy↗
PubMed1982

Hodgkin's disease involving the urinary bladder diagnosed by urinary cytology: a case report.

A unique case of lymphocyte depletion Hodgkin's disease of the urinary bladder in a 91-year-old woman was diagnosed by exfoliative cytology on a single passed urine specimen. Subsequent bladder biopsy confirmed the diagnosis. Retrospectively, it was ascertained that the patient had had a previous diagnosis of Hodgkin's disease based on biopsy of a cervical lymph node ten years previously. This is the first case to be reported in which the presence of Reed Sternberg cells in a cytologic preparation of the urine led to the diagnosis of Hodgkin's disease with involvement of the bladder.

Aged↗
PubMed1989

In situ freezing of the urinary bladder: a trigger of rapid development of sodium o-phenylphenate-induced urinary bladder tumors in the rat.

The effect of in situ freezing of the urinary bladder on sodium o-phenylphenate (OPP-Na)-induced urinary bladder tumor development was investigated in male F344 rats. Freezing was performed at the start of the experiment by touching the serosal surface of the bladder with a frozen steel rod. As a result, three out of 27 rats (11%) developed bladder tumors within 78 weeks when 0.5% OPP-Na feeding was started 2 weeks after freezing and one out of 27 rats (4%) when the feeding was started 12 weeks after freezing. 0.5% OPP-Na alone did not induce any bladder lesions. In a second experiment, 19 out of 25 rats (76%) developed bladder tumors (carcinomas in 12 rats and papillomas in seven rats) when 2% OPP-Na was administered from 6 weeks after freezing, whereas only one rat (5%) demonstrated a bladder carcinoma in the group given 2% OPP-Na without prior freezing. In neither experiment were tumors induced by freezing alone. Enzyme histochemistry revealed no remarkable changes in enzyme activities of regenerative hyperplasia induced by freezing. The results indicate that in situ freezing of the urinary bladder acts as a trigger of rapid development of OPP-Na-induced rat urinary bladder tumors.

Animals↗
PubMed1991

[A case of a foreign body in the urinary bladder--a surgical suture needle was found in urinary bladder].

We report a case of an unusual foreign body in the urinary bladder. A 66-year-old male had undergone an operation of rectal cancer 6 years previously. He visited our hospital with irritative urinary symptoms. Urinalysis showed hematopyuria, and X-ray examination revealed a curved fine shadow (about 2 cm in length and 3 mm in width) at the vesical region. In cystoscopic examination, a calcified surgical suture needle was identified on the trigonal region. The needle was removed transurethrally by a stone crushing forceps. Thus, it was assumed that the needle had been left in the abdominal cavity at the operation 6 years ago and it had migrated into the bladder during these 6 years. Many cases of foreign bodies in the urinary bladder have been reported. However, to our knowledge, this is the first report of a surgical suture needle, in the bladder.

Aged↗
PubMed1988

Effects of alpha-difluoromethylornithine on initiation and promotion of urinary bladder carcinogenesis in a heterotopically transplanted rat urinary bladder.

We previously demonstrated that repeated intravesical instillation of DFMO, an irreversible inhibitor of ornithine decarboxylase, inhibits (or retards) urinary bladder carcinogenesis in rats. The present investigation was conducted to determine if high intraluminal concentration of DFMO alters initiation by MNU and to determine if DFMO inhibition is due to arrest of tumor progression or simply retardation of the tumor development. Results showed that the inhibitory effects demonstrated by DFMO treatment during the early phase of study disappeared as the observation period was extended. Failure to suppress tumor development might be due to failure to control intracellular polyamine levels below the critical level and this failure in turn might be due to the rapid fall of intravesical DFMO concentration following instillation.

Animals↗
PubMed1978

The use of resin-sprayed thin paper for urinary bladder regeneration.

Urinary bladder reconstruction using resin-sprayed thin paper was performed on four patients with either bladder cancer or tuberculosis. The paper was transurethrally removed after the bladder regenerated. Satisfactory results were obtained in three patients; the patient with a long standing tuberculous cicatrical contracted bladder, however, failed to regenerate the bladder with an adequate capacity.

Aged↗
PubMedDate not supplied

Urinary cytology for carcinoma in situ of the urinary bladder.

The urinary cytologies of 14 nonpapillary carcinomas in situ of the urinary bladder were reviewed. Cytologic malignancy was often diagnosed before any clinical manifestation or cytoscopic lesion could be perceived. The cytologic characteristics of this lesion as previously described in the literature were confirmed: the background was usually clean and the tumor cells were numerous and relatively monomorphic, with many atypias. Taking into consideration the limitations discussed, urinary cytology should be regarded as having great accuracy in the early diagnosis of in situ carcinoma of the urinary bladder.

Carcinoma in Situ↗
PubMed1985

Possible involvement of adenine nucleotides in the neurotransmission of the mouse urinary bladder.

The urinary bladder of the mouse contracts to several agonists, namely acetylcholine, noradrenaline, adrenaline, histamine, angiotensin, serotonin, purine nucleotides and prostaglandin F2 alpha. Atropine partially reduced the contraction induced by electrical stimulation, whereas propranolol and tolazoline were ineffective. The atropine resistant component of the neurogenic response was reduced by indomethacin. Methysergide and diphenhydramine were ineffective. Desensitization of the bladder by alpha,beta-methylene ATP abolished the response to ATP and greatly reduced the non-adrenergic non-cholinergic component of the neurogenic response. The results suggest that ATP could be the transmitter responsible for the non-cholinergic non-adrenergic contraction of the mouse urinary bladder.

Acetylcholine↗